6,945 research outputs found
Doppler radar monitoring of lava dome processes at Merapi Volcano, Indonesia
Merapi volcano in Central Java, Indonesia, is considered one of the most dangerous volcanoes worldwide. Due to the high viscosity of its magma, the lava emerging at the top the volcano cannot flow silently down the flanks of the volcano but builds a lava dome. An indicator for the stability of the lava dome are rockfalls and block and ash flows, which are caused by local instabilities at the dome. When the lava dome reaches a critical size, it collapses. This results in dangerous block and ash flows, which can reach several kilometers into the proximity of the volcano. In the past rockfall and block and ash flow activity has been observed visually or by seismic networks. However, visual observations are often impossible due to bad visibility conditions and until now seismic measurements allow only few insights into the dynamic processes that are involved in instability events, i.e. events of material breaks off the lava dome. In order to enhance monitoring of lava dome activity, a first prototype Doppler radar system has been installed at the western of the Merapi in October 2001. This system consists of a frequency modulated continuous wave (FMCW) 24GHz Doppler radar. The Doppler spectra recorded by the system give a relative measure of the amount of material moving through the beam as well as information about its velocities. Because the radar system is insensitive for clouds, the system provides first continuous "quasi-visual" observations of dome instabilities...thesi
Combined Diffusion-Relaxometry MRI to Identify Dysfunction in the Human Placenta
Purpose: A combined diffusion-relaxometry MR acquisition and analysis
pipeline for in-vivo human placenta, which allows for exploration of coupling
between T2* and apparent diffusion coefficient (ADC) measurements in a sub 10
minute scan time.
Methods: We present a novel acquisition combining a diffusion prepared
spin-echo with subsequent gradient echoes. The placentas of 17 pregnant women
were scanned in-vivo, including both healthy controls and participants with
various pregnancy complications. We estimate the joint T2*-ADC spectra using an
inverse Laplace transform.
Results: T2*-ADC spectra demonstrate clear quantitative separation between
normal and dysfunctional placentas.
Conclusions: Combined T2*-diffusivity MRI is promising for assessing fetal
and maternal health during pregnancy. The T2*-ADC spectrum potentially provides
additional information on tissue microstructure, compared to measuring these
two contrasts separately. The presented method is immediately applicable to the
study of other organs
Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis
Peer reviewedPublisher PD
Improving the Clinical Use of Magnetic Resonance Spectroscopy for the Analysis of Brain Tumours using Machine Learning and Novel Post-Processing Methods
Magnetic Resonance Spectroscopy (MRS) provides unique and clinically relevant information for the assessment of several diseases. However, using the currently available tools, MRS processing and analysis is time-consuming and requires profound expert knowledge. For these two reasons, MRS did not gain general acceptance as a mainstream diagnostic technique yet, and the currently available clinical tools have seen little progress during the past years.
MRS provides localized chemical information non-invasively, making it a valuable technique for the assessment of various diseases and conditions, namely brain, prostate and breast cancer, and metabolic diseases affecting the brain. In brain cancer, MRS is normally used for: (1.) differentiation between tumors and non-cancerous lesions, (2.) tumor typing and grading, (3.) differentiation between tumor-progression and radiation necrosis, and (4.) identification of tumor infiltration. Despite the value of MRS for these tasks, susceptibility differences associated with tissue-bone and tissue-air interfaces, as well as with the presence of post-operative paramagnetic particles, affect the quality of brain MR spectra and consequently reduce their clinical value. Therefore, the proper quality management of MRS acquisition and processing is essential to achieve unambiguous and reproducible results. In this thesis, special emphasis was placed on this topic.
This thesis addresses some of the major problems that limit the use of MRS in brain tumors and focuses on the use of machine learning for the automation of the MRS processing pipeline and for assisting the interpretation of MRS data. Three main topics were investigated: (1.) automatic quality control of MRS data, (2.) identification of spectroscopic patterns characteristic of different tissue-types in brain tumors, and (3.) development of a new approach for the detection of tumor-related changes in GBM using MRSI data.
The first topic tackles the problem of MR spectra being frequently affected by signal artifacts that obscure their clinical information content. Manual identification of these artifacts is subjective and is only practically feasible for single-voxel acquisitions and in case the user has an extensive experience with MRS. Therefore, the automatic distinction between data of good or bad quality is an essential step for the automation of MRS processing and routine reporting.
The second topic addresses the difficulties that arise while interpreting MRS results: the interpretation requires expert knowledge, which is not available at every site. Consequently, the development of methods that enable the easy comparison of new spectra with known spectroscopic patterns is of utmost importance for clinical applications of MRS.
The third and last topic focuses on the use of MRSI information for the detection of tumor-related effects in the periphery of brain tumors. Several research groups have shown that MRSI information enables the detection of tumor infiltration in regions where structural MRI appears normal. However, many of the approaches described in the literature make use of only a very limited amount of the total information contained in each MR spectrum. Thus, a better way to exploit MRSI information should enable an improvement in the detection of tumor borders, and consequently improve the treatment of brain tumor patients.
The development of the methods described was made possible by a novel software tool for the combined processing of MRS and MRI: SpectrIm. This tool, which is currently distributed as part of the jMRUI software suite (www.jmrui.eu), is ubiquitous to all of the different methods presented and was one of the main outputs of the doctoral work.
Overall, this thesis presents different methods that, when combined, enable the full automation of MRS processing and assist the analysis of MRS data in brain tumors. By allowing clinical users to obtain more information from MRS with less effort, this thesis contributes to the transformation of MRS into an important clinical tool that may be available whenever its information is of relevance for patient management
Quarterly literature review of the remote sensing of natural resources
The Technology Application Center reviewed abstracted literature sources, and selected document data and data gathering techniques which were performed or obtained remotely from space, aircraft or groundbased stations. All of the documentation was related to remote sensing sensors or the remote sensing of the natural resources. Sensors were primarily those operating within the 10 to the minus 8 power to 1 meter wavelength band. Included are NASA Tech Briefs, ARAC Industrial Applications Reports, U.S. Navy Technical Reports, U.S. Patent reports, and other technical articles and reports
Clinical trials of MRS methods
In order to determine the applicability of noninvasive magnetic resonance spectroscopy (MRS) to the study of a diseased tissue or organ in the human body, it is necessary to determine if MRS is safe and effective. This is the primary purpose of a clinical trial. A clinical trial for MRS may also reveal which technical approach works best for the specific application and characteristics of the population being studied. In this chapter, we discuss the legal, ethical, and scientific requirements to be considered prior to the start of a clinical trial of an MRS protocol, as well as constraints that may arise during its execution. MRS-specific issues arising from a couple of successful clinical MRS trials for classifying brain tumors with 1H MRS (INTERPRET and eTUMOUR) and body tumors with 31P MRS (the Cooperative Group on MRS Application in Cancer, CoGMAC), serve as illustrative examples.JRG thanks The University of Cambridge, CRUK [grant number C14303/A17197] and Hutchison Whampoa Limited. FAM thanks the National Cancer Institute (NIH) from the United States for their support through grants R01-CA118559 and R21-CA152858. FAM wish to thank Dr. Radka Stoyanova from the University of Miami for helpful contributions to the principal component analysis discussion. MJ is funded by SAF2014-52332-R from MINECO (ES) and CIBER-BBN (Centro de Investigación Biomédica en Red – Bioingeniería, Biomateriales y Nanomedicina [http://www.ciber-bbn.es/en]), an initiative of the Instituto de Salud Carlos III (Spain) co-funded by EU FEDER funds.This is the author accepted manuscript. The final version is available from Wiley via http://dx.doi.org/10.1002/9780470034590.emrstm147
- …